Products
By Team
Sales
Multithread effectively and personalize outreach to convert deals faster
Social Media Marketing
Elevate social presence and drive business growth from social media
RevOps
Identify and prioritize high-intent leads, and improve sales effectiveness
Events & Field Marketing
Find and connect with ICP attendees, and improve event outcomes
Resources
.png)
.png)
Envisagenics
What Does Envisagenics Do?
Envisagenics is a pioneering biotechnology company at the intersection of artificial intelligence (AI) and RNA splicing. They leverage their proprietary AI/ML platform, SpliceCore®, to identify novel drug targets and develop RNA-based therapeutics, primarily focusing on oncology and neurodegenerative diseases. By deciphering the complexities of RNA splicing, Envisagenics aims to accelerate the discovery of innovative treatments for diseases with high unmet medical needs.
Where Is Envisagenics's Headquarters?
HQ Function
Serves as the central hub for research and development, AI platform development, strategic partnerships, and corporate operations.
Notable Features:
Located within the Alexandria Center for Life Science, offering access to state-of-the-art lab facilities, a collaborative biotech ecosystem, and resources conducive to cutting-edge research.
Work Culture:
A dynamic, innovative, and research-intensive environment, fostering collaboration between computational biologists, data scientists, and drug development experts. Emphasis on scientific rigor and translational impact.
HQ Significance:
Its location in a major biotech hub provides strategic advantages, including access to talent, research collaborations, and investment opportunities, crucial for a company focused on AI-driven drug discovery.
Values Reflected in HQ: Innovation, collaboration, scientific excellence, and a commitment to translating research into therapies.
Location:
While headquartered in New York City, Envisagenics's impact is global through its AI-driven drug discovery platform and potential therapeutic candidates. The company engages in collaborations with international research institutions and pharmaceutical partners, and its research into diseases like cancer and neurodegenerative disorders addresses global health challenges.
Street Address:
430 East 29th Street, Suite 940
City:
New York
State/Province:
NY
Country:
USA
Where Else Does Envisagenics Operate Around the World?
No additional office locations available.
Buying Intent Signals for Envisagenics
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
Who's Leading Envisagenics? Meet the Executive Team
As of April 2025, Envisagenics' leadership includes:
Who's Investing in Envisagenics?
Envisagenics has been backed by several prominent investors over the years, including:
What Leadership Changes Has Envisagenics Seen Recently?
Based on publicly available information, there have been no major executive team hires or exits announced by Envisagenics in the last 12 months (approximately mid-2023 to mid-2024). The core leadership team appears stable.
What Technology (Tech Stack) Is Used byEnvisagenics?
Discover the tools Envisagenics uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Envisagenics Email Formats and Examples
Envisagenics likely utilizes standard corporate email formats. Based on common patterns for companies of its size and industry, the most probable format is the first initial followed by the last name.
[first_initial][last]@envisagenics.com
Format
mpineda@envisagenics.com
Example
75%
Success rate
What's the Latest News About Envisagenics?
Business Wire • June 27, 2023
Envisagenics Presents Data at AACR Special Conference Demonstrating SpliceCore’s Ability to Discover Novel Tumor-Specific Antigens from RNA Splicing Events
Envisagenics presented data at the American Association for Cancer Research (AACR) Special Conference showcasing its SpliceCore® platform's capability to identify novel tumor-specific antigens derived from RNA splicing events, highlighting potential for new cancer immunotherapies....more
Business Wire • May 16, 2023
Envisagenics Extends Series A Financing to $23.5M to Advance AI-Driven RNA Splicing Drug Discovery Platform
Envisagenics announced an extension of its Series A financing, bringing the total to $23.5 million. The funding, led by existing investor Third Kind Venture Capital and new investor Coatue, will be used to scale its SpliceCore® AI platform and advance its pipeline of RNA splicing-based therapeutics....more
PR Newswire • January 5, 2023
Envisagenics Announces Research Collaboration with Bristol Myers Squibb to Accelerate a Biologics Drug Discovery Program Using AI
Envisagenics entered into a research collaboration with Bristol Myers Squibb to leverage its AI-powered SpliceCore platform for identifying novel targets for biologics, aiming to accelerate drug discovery in oncology....more
Highperformr's free tools for company research
Explore Employees by Region or Country
See where a company’s workforce is located, by country or region.
View Funding Details
View past and recent funding rounds with amounts and investors.
Understand Revenue Insights
Understand company revenue estimates and financial scale.
Track Active Job Openings
Track active roles and hiring trends to spot growth signals.
Review Product and Offerings
Discover what a company offers—products, platforms, and solutions.
Get SIC or NAICS Codes
Get the company’s official SIC and NAICS classifications.
Analyze Website Traffic Trends
Analyze visitor volume, engagement, and top traffic sources.
Discover Social Profiles and Engagement
Explore LinkedIn, Twitter, and other active social profiles.
Identify Top Competitors
Identify top competitors based on similar business traits.
Research and Discover Companies with Highperformr — Smarter, Faster
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
- Track intent signals to find buyers who are actively in-market
- Enrich contacts and companies instantly, no need to switch tools
- Automate workflows to stay ahead of every change
- Connect your CRM & tools for seamless data sync and activation
Thousands of companies, including Envisagenics, are just a search away.